<DOC>
	<DOC>NCT01397084</DOC>
	<brief_summary>Administration of esomeprazole 20 mg to subjects who still had heartburn after receiving rabeprazole 10 mg once daily for at least 4 weeks will result in statistically significant improvement of heartburn after 8-week treatment.</brief_summary>
	<brief_title>To Assess the Efficacy of Esomeprazole 20mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Heartburn</mesh_term>
	<mesh_term>Esophagitis, Peptic</mesh_term>
	<mesh_term>Rabeprazole</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Male of female aged 20 years or more History of reflux esophagitis Ongoing (until date of Visit 1) treatment with rabeprazole 10 mg, given once daily, for at least 4 weeks.The subject must take rabeprazole at least 4 days a week in the past 7 days prior to Visit 1. Persisting symptoms of heartburn experienced at least 2 days during the past 7 days prior to Visit 1. Use of other PPIs and/or H2RA during rabeprazole treatment History or having other gastrointestinal diseases History of upper gastrointestinal surgery Initiation of medications that can affect digestive functions within 4 weeks before study treatment Inability to complete questionnaires</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>esomeprazole 20mg</keyword>
	<keyword>heartburn</keyword>
	<keyword>rabeprazole 10mg</keyword>
	<keyword>reflux esophagitis</keyword>
	<keyword>Phase IV</keyword>
</DOC>